Literature DB >> 30676436

A Retrospective Analysis of Antithrombin III Replacement Therapy for the Treatment of Hepatic Sinusoidal Obstruction Syndrome in Children Following Hematopoietic Stem Cell Transplantation.

Miriam Kim1, Seema Rao1,2, Jens C Eickhoff3, Kenneth B DeSantes1, Christian M Capitini1.   

Abstract

Hepatic sinusoidal obstruction syndrome (SOS) remains a serious complication of hematopoietic stem cell transplantation (HSCT). In this single institution retrospective case series, 18 children developed SOS after HSCT. Patients were treated with antithrombin III (ATIII), defibrotide, or ATIII followed by defibrotide. Twelve of 13 patients who were treated with ATIII therapy alone had complete resolution of SOS, including 4 of 5 children with severe SOS. In this limited cohort, ATIII was safe and successfully prevented progression of hepatic SOS following HSCT in the majority of children at our center.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 30676436      PMCID： PMC6646100          DOI： 10.1097/MPH.0000000000001422

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.170


  17 in total

1.  Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin.

Authors:  M Simon; T Hahn; L A Ford; B Anderson; D Swinnich; M R Baer; B Bambach; S H Bernstein; Z P Bernstein; M S Czuczman; J L Slack; M Wetzler; G Herzig; J Schriber; P L McCarthy
Journal:  Bone Marrow Transplant       Date:  2001-03       Impact factor: 5.483

2.  Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III.

Authors:  M Uchiba; K Okajima; K Murakami; H Okabe; K Takatsuki
Journal:  Am J Physiol       Date:  1996-06

3.  The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation.

Authors:  K Ohashi; J Tanabe; R Watanabe; T Tanaka; H Sakamaki; A Maruta; S Okamoto; N Aotsuka; K Saito; M Nishimura; H Oh; M Matsuzaki; S Takahashi; S Yonekura
Journal:  Am J Hematol       Date:  2000-05       Impact factor: 10.047

4.  Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease.

Authors:  Edward Peres; Polly Kintzel; Roger Dansey; Roy Baynes; Muneer Abidi; Jared Klein; Rami B Ibrahim; Esteban Abella
Journal:  Blood Coagul Fibrinolysis       Date:  2008-04       Impact factor: 1.276

5.  A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation.

Authors:  S I Bearman; D D Shen; M S Hinds; H A Hill; G B McDonald
Journal:  Br J Haematol       Date:  1993-08       Impact factor: 6.998

Review 6.  Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.

Authors:  Jason A Coppell; Paul G Richardson; Robert Soiffer; Paul L Martin; Nancy A Kernan; Allen Chen; Eva Guinan; Georgia Vogelsang; Amrita Krishnan; Sergio Giralt; Carolyn Revta; Nicole A Carreau; Massimo Iacobelli; Enric Carreras; Tapani Ruutu; Tiziano Barbui; Joseph H Antin; Dietger Niederwieser
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-18       Impact factor: 5.742

7.  Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients.

Authors:  C C Barker; J D Butzner; R A Anderson; R Brant; R S Sauve
Journal:  Bone Marrow Transplant       Date:  2003-07       Impact factor: 5.483

8.  Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients.

Authors:  G B McDonald; M S Hinds; L D Fisher; H G Schoch; J L Wolford; M Banaji; B J Hardin; H M Shulman; R A Clift
Journal:  Ann Intern Med       Date:  1993-02-15       Impact factor: 25.391

9.  Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.

Authors:  Paul G Richardson; Marcie L Riches; Nancy A Kernan; Joel A Brochstein; Shin Mineishi; Amanda M Termuhlen; Sally Arai; Stephan A Grupp; Eva C Guinan; Paul L Martin; Gideon Steinbach; Amrita Krishnan; Eneida R Nemecek; Sergio Giralt; Tulio Rodriguez; Reggie Duerst; John Doyle; Joseph H Antin; Angela Smith; Leslie Lehmann; Richard Champlin; Alfred Gillio; Rajinder Bajwa; Ralph B D'Agostino; Joseph Massaro; Diane Warren; Maja Miloslavsky; Robin L Hume; Massimo Iacobelli; Bijan Nejadnik; Alison L Hannah; Robert J Soiffer
Journal:  Blood       Date:  2016-01-29       Impact factor: 22.113

10.  Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.

Authors:  S Corbacioglu; E Carreras; M Ansari; A Balduzzi; S Cesaro; J-H Dalle; F Dignan; B Gibson; T Guengoer; B Gruhn; A Lankester; F Locatelli; A Pagliuca; C Peters; P G Richardson; A S Schulz; P Sedlacek; J Stein; K-W Sykora; J Toporski; E Trigoso; K Vetteranta; J Wachowiak; E Wallhult; R Wynn; I Yaniv; A Yesilipek; M Mohty; P Bader
Journal:  Bone Marrow Transplant       Date:  2017-07-31       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.